Investigational drug with immunotherapy may provide new...
Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may offer a potential new...
Rogers Award honors Sheryl Harris, C.N.A., for excellence...
The University of Texas MD Anderson Cancer Center has awarded Sheryl Harris, C.N.A., the Julie and Ben Rogers Award for Excellence in...
MD Anderson and Houston Dynamo unite to kick childhood...
The University of Texas MD Anderson Cancer Center goes gold for Kick Childhood Cancer Awareness Night at BBVA Stadium, Saturday, Sept....
In Memory of T. Boone Pickens
The University of Texas MD Anderson Cancer Center extends deepest sympathy to family and friends of philanthropist and energy industry tycoon T. Boone Pickens. The institution mourns the loss of the
visionary leader who long served as a passionate ambassador of MD Anderson and its mission to end cancer.
“We are forever grateful to Boone for bringing his creative spirit and ingenuity to the global fight to end...
MD Anderson study confirms protein as potential cause of...
Researchers at The University of Texas MD Anderson Cancer Center have confirmed a protein as an oncogene responsible for the most...